Garvan Institute of Medical Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
29
About the Report
About the Report
Summary
Garvan Institute of Medical Research (Garvan Institute) is a biomedical research institute. The institute conducts research in the fields of cancer, diabetes and obesity, Alzheimer's and Parkinson's disease, asthma, rheumatoid arthritis, osteoporosis, arthritis and pituitary disorders. It also conducts research in various different types of cancer such as breast cancer, prostate cancer, lung cancer, colorectal cancer, ovarian cancer and pancreatic cancer. Garvan Institute's immunology research includes asthma, type 1 diabetes, rheumatoid arthritis, lupus, Sjogren's syndrome and autoimmune hepatitis, among others. The institute's research capabilities comprise animal imaging, animal research, bioinformatics, flow cytometry, functional genomics, genome editing, biodata visualisation, and others. Garvan Institute is headquartered in Darlinghurst, New South Wales, Australia.
Garvan Institute of Medical Research-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Garvan Institute of Medical Research, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
InvitroCue Enters into Research Agreement with Garvan Institute of Medical Research 10
Personalis Enters into Agreement with Garvan Institute to Provide Genome Sequencing Analysis 11
Roche NimbleGen Enters into Co-Development Agreement with Garvan Institute of Medical Research 12
Licensing Agreements 13
SYNkinase Enters into Licensing Agreement with Garvan and Cancer Therapeutics 13
Garvan Institute of Medical Research-Key Competitors 14
Garvan Institute of Medical Research-Key Employees 15
Garvan Institute of Medical Research-Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Government and Public Interest 17
Sep 03, 2018: Gene-hunters make sense of a new immune disease 17
Jul 26, 2018: Turbo-charging chemotherapy for lung cancer 19
Jul 25, 2018: Trials for young adults with cancer to receive huge funding boost 21
Jul 18, 2018: Bringing genomic cancer medicine home 22
Dec 13, 2017: Study Reveals A Role For Micro-RNAS In Cancer Cell Survival 24
Jul 17, 2017: Australian Cancer Research Foundation: Interleukin-2 Immunotherapy Improved 25
Other Significant Developments 27
Jun 13, 2018: Setting Sights On Pancreatic Cancer'S Moving Targets 27
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29
List of Figure
List of Figures
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List of Table
List of Tables
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare, Key Facts 2
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Garvan Institute of Medical Research, Deals By Therapy Area, 2012 to YTD 2018 8
Garvan Institute of Medical Research, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
InvitroCue Enters into Research Agreement with Garvan Institute of Medical Research 10
Personalis Enters into Agreement with Garvan Institute to Provide Genome Sequencing Analysis 11
Roche NimbleGen Enters into Co-Development Agreement with Garvan Institute of Medical Research 12
SYNkinase Enters into Licensing Agreement with Garvan and Cancer Therapeutics 13
Garvan Institute of Medical Research, Key Competitors 14
Garvan Institute of Medical Research, Key Employees 15
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.